A detailed history of Hennion & Walsh Asset Management, Inc. transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, Hennion & Walsh Asset Management, Inc. holds 38,043 shares of BBIO stock, worth $1.01 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
38,043
Previous 39,099 2.7%
Holding current value
$1.01 Million
Previous $990,000 2.22%
% of portfolio
0.05%
Previous 0.05%

Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 22, 2024

SELL
$23.91 - $31.3 $25,248 - $33,052
-1,056 Reduced 2.7%
38,043 $968,000
Q2 2024

Jul 19, 2024

SELL
$23.0 - $31.04 $2.41 Million - $3.26 Million
-104,995 Reduced 72.87%
39,099 $990,000
Q1 2024

Apr 17, 2024

BUY
$27.35 - $40.45 $613,761 - $907,738
22,441 Added 18.45%
144,094 $4.46 Million
Q4 2023

Jan 10, 2024

BUY
$24.02 - $43.89 $808,801 - $1.48 Million
33,672 Added 38.27%
121,653 $4.91 Million
Q3 2023

Oct 27, 2023

BUY
$16.89 - $35.01 $59,013 - $122,324
3,494 Added 4.14%
87,981 $2.32 Million
Q2 2023

Aug 09, 2023

SELL
$13.29 - $18.01 $30,248 - $40,990
-2,276 Reduced 2.62%
84,487 $1.45 Million
Q1 2023

Apr 20, 2023

SELL
$7.17 - $18.55 $19,660 - $50,864
-2,742 Reduced 3.06%
86,763 $1.44 Million
Q4 2022

Jan 12, 2023

BUY
$6.74 - $11.52 $75,164 - $128,471
11,152 Added 14.23%
89,505 $682,000
Q3 2022

Nov 14, 2022

BUY
$7.94 - $12.36 $154,893 - $241,118
19,508 Added 33.15%
78,353 $779,000
Q2 2022

Jul 19, 2022

BUY
$5.21 - $12.14 $306,582 - $714,378
58,845 New
58,845 $534,000

Others Institutions Holding BBIO

About BridgeBio Pharma, Inc.


  • Ticker BBIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 148,246,000
  • Market Cap $3.92B
  • Description
  • BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...
More about BBIO
Track This Portfolio

Track Hennion & Walsh Asset Management, Inc. Portfolio

Follow Hennion & Walsh Asset Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hennion & Walsh Asset Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Hennion & Walsh Asset Management, Inc. with notifications on news.